|
|
|
|
A more recent version of this article appeared on April 1, 2007
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on August 17, 2006
Revised on December 18, 2006
Accepted on January 24, 2007
*Department of Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104;
Department of Cell and Developmental Biology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104;
Department of Neurology and Neurobiology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213
Monitoring Editor: Francis Barr
NGF induces neurite outgrowth and differentiation in a process that involves NGF binding to its receptor TrkA and endocytosis of the NGF-TrkA complex into signaling endosomes. Here we find that biogenesis of signaling endosomes requires inactivation of Rab5 to block early endosome fusion. Expression of dominant negative Rab5 mutants enhanced NGF-mediated neurite outgrowth, while a constitutive active Rab5 mutant or Rabex-5 inhibited this process. Consistently inactivation of Rab5 sustained TrkA activation on the endosomes. Furthermore, NGF treatment rapidly decreased cellular level of active Rab5-GTP, as shown by pull-down assays. This Rab5 down-regulation was mediated by RabGAP5, which was shown to associate with TrkA by coimmunoprecipitation assays. Importantly RNAi of RabGAP5 as well as a RabGAP5 truncation mutant containing the TrkA-binding domain blocked NGF-mediated neurite outgrowth, indicating a requirement for RabGAP5 in this process. Thus NGF signaling down-regulates Rab5 activity via RabGAP5 to facilitate neurite outgrowth and differentiation.